Evaluate the Efficacy, Safety and Tolerability of HLX26 and Serplulimab in Patients With mCRC
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
This study is a phase II study to evaluate the efficacy, safety and tolerability of HLX26 and HLX10 in the treatment of patients with metastatic colorectal carcinoma that had received 3 prior therapies.
创建时间：
2023-06-15
